Peter Chambré
Non-Executive Chairman
Non-Executive Chairman
Peter Chambré was appointed as Senior Adviser by 3i in September 2007 to identify and lead transforming investments into high potential healthcare companies. His most recent role prior to this...
read more >
read more >
Simon Cartmell BSc (Hons), MSc
Chief Executive Officer
Chief Executive Officer
Simon Cartmell has 24 years pharmaceutical, healthcare and biotechnology industry experience. He spent 17 years at GlaxoWellcome in a number of U.K. and global roles, including Therapy Area...
read more >
read more >
Bruce Powell MA, FCA
Chief Financial Officer
Chief Financial Officer
Bruce Powell was trained as a chartered accountant with Coopers & Lybrand in London. He has worked for many years in the IT industry and was finance director of Acal Group plc and Videologic Group...
read more >
read more >
Professor William Bonfield CBE,
Director, ApaTech™
Director, ApaTech™
Professor Bonfield was Director of the University of London Interdisciplinary Research Centre (IRC) in Biomedical Materials, based at Queen Mary and Westfield College from 1991 until 1999. During...
read more >
read more >
Nigel Pitchford
Investor Director
Investor Director
Nigel is a partner in 3i's healthcare team and is based in London. Having joined 3i's venture team in 1997, Nigel has been responsible for leading many 3i investments. Examples of these include...
read more >
read more >
Michael Mashaal MD
Investor Director
Investor Director
Dr. Mashaal joined the HealthCor Group in May 2005. Prior to joining the private equity team in mid-2006, Dr. Mashaal was a Senior Research Analyst focused on biotechnology for the HealthCor Group....
read more >
read more >

